These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18384959)

  • 1. Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: how study designs can affect placebo factors.
    Staud R; Price DD
    Pain; 2008 Jun; 136(3):232-234. PubMed ID: 18384959
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to: Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: How study designs can affect placebo factors.
    Moore RA; Derry S; McQuay HJ
    Pain; 2008 Oct; 139(2):477-479. PubMed ID: 18790568
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial.
    Russell JI; Mease PJ; Smith TR; Kajdasz DK; Wohlreich MM; Detke MJ; Walker DJ; Chappell AS; Arnold LM
    Pain; 2008 Jun; 136(3):432-444. PubMed ID: 18395345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin.
    Crofford LJ; Mease PJ; Simpson SL; Young JP; Martin SA; Haig GM; Sharma U
    Pain; 2008 Jun; 136(3):419-431. PubMed ID: 18400400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication dosing patterns associated with duloxetine and pregabalin among patients with fibromyalgia.
    Sun P; Zhao Y; Zhao Z; Watson P
    Curr Med Res Opin; 2011 Sep; 27(9):1793-801. PubMed ID: 21810060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective.
    Choy E; Richards S; Bowrin K; Watson P; Lloyd A; Sadosky A; Zlateva G
    Curr Med Res Opin; 2010 Apr; 26(4):965-75. PubMed ID: 20178405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and medication uses among fibromyalgia patients newly prescribed amitriptyline, duloxetine, gabapentin, or pregabalin.
    Kim SC; Landon JE; Solomon DH
    Arthritis Care Res (Hoboken); 2013 Nov; 65(11):1813-9. PubMed ID: 23861291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregabalin in fibromyalgia--responder analysis from individual patient data.
    Straube S; Derry S; Moore RA; Paine J; McQuay HJ
    BMC Musculoskelet Disord; 2010 Jul; 11():150. PubMed ID: 20602781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibromyalgia coverage uneven despite recent drug approvals.
    Sipkoff M
    Manag Care; 2008 Dec; 17(12):9-10. PubMed ID: 19127758
    [No Abstract]   [Full Text] [Related]  

  • 10. Current progress in the pharmacological therapy of fibromyalgia.
    Rao SG
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1479-93. PubMed ID: 19732029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of fibromyalgia.
    Traynor LM; Thiessen CN; Traynor AP
    Am J Health Syst Pharm; 2011 Jul; 68(14):1307-19. PubMed ID: 21719591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential drug-drug and drug-condition interactions among fibromyalgia patients initiating pregabalin or duloxetine: prevalence and health care expenditure impact.
    Johnston SS; Udall M; Cappelleri JC; Johnson BH; Shrady G; Chu BC; Silverman SL
    Pain Med; 2014 Aug; 15(8):1282-93. PubMed ID: 24401017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evidence-based recommendations for the treatment of fibromyalgia syndrome].
    Harten P; Genth E
    Z Rheumatol; 2010 Jul; 69(5):457-60. PubMed ID: 18836732
    [No Abstract]   [Full Text] [Related]  

  • 14. The cost-effectiveness of pregabalin in the treatment of fibromyalgia: US perspective.
    Lloyd A; Boomershine CS; Choy EH; Chandran A; Zlateva G
    J Med Econ; 2012; 15(3):481-92. PubMed ID: 22339078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health care costs in patients with fibromyalgia on pregabalin vs. duloxetine.
    Burke JP; Sanchez RJ; Joshi AV; Cappelleri JC; Kulakodlu M; Halpern R
    Pain Pract; 2012 Jan; 12(1):14-22. PubMed ID: 21615857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy of fibromyalgia.
    Mease PJ; Dundon K; Sarzi-Puttini P
    Best Pract Res Clin Rheumatol; 2011 Apr; 25(2):285-97. PubMed ID: 22094202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and tolerability of duloxetine, pregabalin, and milnacipran for the treatment of fibromyalgia: a Bayesian network meta-analysis of randomized controlled trials.
    Lee YH; Song GG
    Rheumatol Int; 2016 May; 36(5):663-72. PubMed ID: 27000046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain.
    Tesfaye S; Wilhelm S; Lledo A; Schacht A; Tölle T; Bouhassira D; Cruccu G; Skljarevski V; Freynhagen R
    Pain; 2013 Dec; 154(12):2616-2625. PubMed ID: 23732189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatment of fibromyalgia syndrome: new developments.
    Staud R
    Drugs; 2010; 70(1):1-14. PubMed ID: 20030422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial.
    Gilron I; Chaparro LE; Tu D; Holden RR; Milev R; Towheed T; DuMerton-Shore D; Walker S
    Pain; 2016 Jul; 157(7):1532-40. PubMed ID: 26982602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.